The retention of salt and water by patients receiving ACTH and cortisone is well known (1). If sufficiently marked, rapid weight gain, edema and pulmonary congestion may result. It was considered of interest, therefore, to study the changes in plasma volume, extracellular fluid volume, total body water, and total body chloride occurring in patients receiving adrenocorticotropic hormone. A transient increase in the inulin space in patients treated with ACTH and cortisone and maintained on rigid salt restriction has been reported recently by Levitt and Bader (2).
The retention of salt and water by patients receiving ACTH and cortisone is well known (1) . If sufficiently marked, rapid weight gain, edema and pulmonary congestion may result. It was considered of interest, therefore, to study the changes in plasma volume, extracellular fluid volume, total body water, and total body chloride occurring in patients receiving adrenocorticotropic hormone. A transient increase in the inulin space in patients treated with ACTH and cortisone and maintained on rigid salt restriction has been reported recently by Levitt and Bader (2) .
METHODS
Five patients were studied; three had rheumatoid arthritis, one rheumatoid spondylitis, and one rheumatic fever with polyarthritis. Three patients were males and two females; their ages ranged between 28 and 53. In order not to limit the magnitude of the expected physiological changes, salt intake was not restricted. The amount of salt taken by shaker along with the regular hospital diet was, however, weighed daily, and proved to be relatively constant for each patient, varying between 1 and 3 grams per day.
Following a preliminary control study, the patients were treated with ACTH in dosages of 100 to 120 mg.
per day' for about four weeks. Three patients, E. S., M. U., and G. R., received a supplement of 3 grams of KCl per day. Volume studies, determination of serum Nat, Cl-and HCOi-levels, complete blood and eosinophil counts, and determination of E.S.R. and hematocrit were done at approximately weekly intervals during treatment and also at intervals varying from six to 14 days following the end of ACTH administration.
T 1824 space, antipyrine space and bromide space were measured simultaneously; total body chloride was estimated.
T1824 space: Plasma volume was measured by the T 1824 dye method (3) . Blood samples were taken 10 and 20 minutes following dye administration.
Antipyrine space: This was determined by the method of Soberman and his associates (4a) . Approximately 1.5 grams of antipyrine4 were infused simultaneously with sodium bromide from a calibrated burette. The exact amounts of antipyrine as well as of bromide infused were established by direct analysis of the infused solutions. In non-edematous patients, samples were taken at two, three, four and five hours. In the two patients who developed significant peripheral edema, samples were taken at three, five, seven, and eight hours. It was demonstrated that the presence of T 1824 dye in the plasma did not increase the ultraviolet absorption of the plasma filtrates at 350 my after nitrosation, and it was concluded from this that T 1824 does not interfere with the determination of antipyrine.
Bromide space: This was measured by the method of Brodie and Friedman (5). From 1.5 to 2 grams of bromide were infused as sodium bromide in 2%o solution with the antipyrine. Correction for Donnan equilibrium and plasma water concentration was made by dividing the serum concentration by the factor 0.88. Fusion of the plasma samples eliminated possible interference from T 1824 and antipyrine in the analysis of bromide. When known amounts of bromide were added to plasma, 98 to 102% were recovered.
Brodie, Brand, and Leshin (6) have shown that bromide arrives at diffusion equilibrium in humans within 2.5 hours and Berger and his coworkers (7) have demonstrated that bromide equilibrates between plasma and pleural fluid in dogs in two to four hours. The latter authors and Dunning, Steele, and Berger (8) analyzed five hour blood samples in non-edematous patients. Eliel, Pearson, and Rawson (9) averaged the four and five hour samples. Bromide excretion has been neglected during the five hour period in the investigations cited because it comprises approximately 17o of the administered bromide (9) . In order to establish the time of diffusion equilibrium of bromide, measurements of the bromide space were made in eight subjects not previously included; five were given no hormone, two received ACTH * This substance was kindly provided in sterile ampules by Eli Lilly and Co. noted in all patients treated with this hormone except E. S.5
RESULTS
It may be seen from Table I that in untreated as well as in ACTH treated patients who had not received bromide previously, bromide spaces at four, five, seven and 24 hours were essentially equivalent. In Table II are presented measurements of the bromide space in ACTH treated patients who had received bromide in previous experiments and in whom the zero hour blank was corrected for excretion during the 24 hour period as described. The five and 24 hour spaces are in good agreement.
In order to determine the precision of the determinations used, T 1824, antipyrine and bromide spaces were measured four times within a one week period in the same individual, a 46-year-old man with moderately advanced rheumatoid arthritis (Table III) . The widest variation in four determinations was 0.2 liter in the T 1824 space, 1.2 liters in the bromide space, 1.5 liters in the antipyrine space, and 130 mEq. in the calculated body chloride.
In Figures 1 to 5 are plotted the changes in bromide space, total body chloride, antipyrine 5 In this patient, the eosinophil count, initially 321, fell to 108 after 14 days and to 21 after 17 days of ACTH administration, remaining reduced during the remainder of the period of hormonal therapy. The pre-treatment 17- Hg.6 Ten days after ACTH therapy was discontinued, marked decreases of approximately equal magnitude had occurred in all compartments measured. The venous pressure had returned to normal, and there was no edema. Serum electrolyte levels (Na+, K+, Cl-, and HCO-) remained within normal limits during and after ACTH administration (Table IV) .
2). G. R., Rheumatoid spondylitis, with peripheral joint involvement, male, age 52
This patient was free of cardiac disease but had 2 + pitting edema of the feet associated with joint involvement of both ankles. As in the preceding patient, after ACTH had been administered for 13 days (Figure 2) 3). M. U., Rheumatoid arthritis, female, age 28 During the first eight days of treatment (Figure 3) , the patient responded like the preceding ones with significant and approximately equal expansions of the antipyrine space, bromide space, total body chlorides, and body weight. After 19 days of treatment, however, the water and weight increments were significantly greater than the expansion of the bromide space, and after 33 days this divergence was even more marked. Whereas the bromide space had increased only 2.2 liters. above the pre-ACTH level, body water had increased 5 liters and the weight 6.5 Kg 
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I. This patient had advanced rheumatoid arthritis and evidence of inactive chronic heart disease, consisting of cardiac enlargement and insufficiency of the mitral valve. There were no signs of failure. Six days after the administration of ACTH, she had retained 420 mEq. of chloride ( Figure 5 ). This was accompanied by an increase of 3.3 liters of the bromide space, but only by a negligible increase in body water and body weight. There was at this time dyspnea at rest, mild pitting edema of the ankles, and a venous pressure of 160 mm. of water. Following space studies, a mercurial diuretic was injected to relieve the symptoms of failure. As ACTH was continued, there was a diminution in the bromide space and body chloride. This was accompanied, however, by a rise in total body water and weight. At 25 days, the bromide space and total chloride had returned almost to control levels whereas total body water had increased, 3.3 liters above the pre-ACTH value. At this time the patient was again complaining of dyspnea and orthopnea, the liver was enlarged, there was edema of the lower extremities and the venous pressure was 160 mm. of water. Blood circulation times were within normal limits. Following space studies, a mercurial diuretic was again given. Five days after ACTH was discontinued, there was a marked diminution of bromide space and total chloride to significantly less than pre-ACTH levels. This was accompanied by smaller, though significant, losses in body weight and water.
T 1824 space showed a steady fall throughout therapy, diminishing from a pre-treatment value of 3.4 liters to a volume of 2.7 liters after 25 days of ACTH, and remaining at approximately this level, five days after the hormone was discontinued. The hematocrit rose from 31 to 37 and the hemoglobin from 10 to 11.5 grams in the course of the 25 day period of ACTH administration. Serum Na+ remained within normal limits throughout the period of observation; K+ concentration fell from 5.1 mEq. to 3.7 mEq. per liter at 25 days; serum chloride varied from 98 to 94 mEq.; and the HCO3-level rose to 29.7 mEq. at this time.
COMMENT
It has been demonstrated (10, 11) that bromide is distributed similarly to chloride in body tissues. The volume of distribution of bromide, like that of chloride, thiocyanate, and sodium, is larger than that of inulin and sucrose (7, 12, 16) , and it has been suggested, for this reason, that approximately 30%o of body chloride (12) is intracellular. If it is accepted that chloride exists intracellularly in significant amounts, expansion of the bromide space induced by ACTH may reflect in part change in intracellular as well as extracellular fluid volume. Antipyrine space (4a) was utilized to measure total body water. Evidence that the volume of distribution of antipyrine is equivalent to total water is the observed agreement between antipyrine space and deuterium oxide (4a) and tritium oxide spaces (4b).
In two patients, F. R. and G. R., there were large increases in total body water, which paralleled quite closely weight gain and expansion of the bromide space. In these patients, it would appear that the increase in body water was associated largely with expansion of the chloride compartment. This is consistent with the fact that both patients developed increasing edema and that in one (F. R.) the venous pressure rose to abnormal levels. In M. U. and L. G., however, the expansion of the chloride compartment did not keep pace with the increase in total body water. This could in part be due to the tendency to loss of chloride with alkalosis which is known to occur in patients with hyperadrenalcorticalism (1), but significant abnormality of serum electrolyte concentrations was not noted in either individual. It is likely that the water increments in M. U. and L. G. represent largely expansion of the intracellular compartment, which is ordinarily associated predominantly with retention of anions other than chloride. This could in great part be due to repair of atrophic muscle tissue, 83%o of which, according to Hastings and Eichelberger (17) , consists of intracellular phase of which 72%o is water.
The history of marked weight loss prior to therapy and the absence of a water diuresis exhibited by L. G., and similarly the small diuresis observed in M. U. following discontinuance of ACTH, are consistent with this explanation. The relatively greater increase in body weight than body water observed in these two cases at the termination of therapy may be explained by the deposition of significant amounts of body fat and tissue solids.
E. S., who had advanced rheumatoid arthritis and also heart disease, showed a pattern of response to ACTH which differed from the other four. There was early increase in body chloride and bromide space, without concurrent expansion of body water or body weight. Simultaneously there appeared symptoms and signs of congestive heart failure. A somewhat similar phenomenon has been reported by Levitt and Bader (2) ,, and has been attributed by these authors to a shift of salt and water extracellularly. In the case of chloride, this would have to arise from stores which previously did not exchange with bromide. With continuation of ACTH therapy and the administration of two mercurial injections, there was a loss of body chloride and, five days after discontinuing ACTH, total body chloride and bromide space were well below pretreatment values.
The plasma volume rose with ACTH administration in three patients and fell in two. In four out of five, changes in plasma volume corresponded fairly well with changes in the bromide space. In G. R., plasma volume fell as bromide space rose.
Jager, Brown and Nickerson (18a) Robinson and Farr (26) administered 30 units of pitressin per day to humans and, though there was an early rise in urinary ADH, it fell rapidly to normal in a few days. The combined effect of ACTH and pitressin on water and salt balance is a subject about which there is as yet little information (27) .
8J-16709R, Armour and Co.
It would appear from the present work, that the amount of water retention, and the manner in which this is retained in response to ACTH varies in different individuals, being in some predominantly extracellular and in others intracellular. Variability of response to adrenal cortical hormones under differing physiological conditions has been noted commonly. Cortisone may, under different circumstances, cause either water retention or water diuresis (27) . Impairment of glucose tolerance may occur in some patients after a brief period of cortisone administration, and in others no impairment is demonstrable even after prolonged administration (28) . Nitrogen balance may be either positive or negative according to existing tissue requirements (29) . It may be that the manner in which water is retained in response to ACTH is determined among other things by the tissue needs of the subject. Thus, water retention appeared to be intracellular in L. G., for example, in whom body solids increased, and extracellular in F. R. in whom body solids did not increase.
SUMMARY
Simultaneous determinations of T 1824, antipyrine and bromide spaces were made before, during and after ACTH therapy in five patients with rheumatic diseases. Total body chloride was calculated at the same time. The following observations were made: 1) On administration of ACTH, marked increases in body water were consistently observed in all cases. 2) In two patients who developed increasing edema on administration of ACTH, one of whom demonstrated elevation of venous pressure, the expansion of antipyrine space and gain in body weight were similar in magnitude to increase in the bromide space, indicating retention of water predominantly in the extracellular compartment. 3) In two patients in whom edema or signs of venous congestion were not evident, increase in antipyrine space and body weight exceeded the increment in bromide space. The water increments in these patients appeared to be due mainly to retention of intracellular water associated with gain in tissue weight. 4) In one patient there was an initial increase in bromide space with retention of chloride, which later diminished in spite of an increase in total body water. 5) T 1824 space rose in three patients and fell in two during administration of ACTH. It varied directly with the bromide space in four patients out of five. 6) The manner of water retention by different individuals in response to ACTH is variable.
